Immunocompromised patients, those at risk for transfusion-associated graft vs. host disease, patients with cancer, recipients of bone marrow transplantation, patients receiving fludarabine.
Sep
18
2021
Sep
18
2021
Immunocompromised patients, those at risk for transfusion-associated graft vs. host disease, patients with cancer, recipients of bone marrow transplantation, patients receiving fludarabine.